A record 3627 cannabis studies completed in 2020
From CBD-addicted drivers to stoned lab rats, cannabis law reform continues to push research to an unprecedented level. Researchers around the world have published a record 3627 cannabis studies in 2020, according to data compiled by the National Library of Medicine the United States.
As more and more jurisdictions have reformed cannabis laws over the past 10 years, scientific interest in this plant has grown exponentially, especially in its therapeutic potential.
Synthesis of knowledge on cannabis in 2020
Scientists have published more than 23000 articles on cannabis since 2010, and the number of studies is increasing every year. By comparison, researchers published fewer than 3000 studies between 1990 and 1999, and less than 2000 in the 1980s.
The majority of research on hemp-derived CBD, compiled by the US NLM on PubMed.gov, was not included in the tally. But the total number of CBD studies has also increased, from 163 in 2000 to a record 1052 in 2020.
In 2020, research has spanned a wide variety of topics, from how cannabis can help fight opioid addiction, post-traumatic stress, and pain, to the effects of cannabinoids on drivers, to the way in which rats share human affinity for THC.
In April, researchers at Washington State University published the results of an experiment, the first of its kind, that allowed rats to self-administer cannabis vapor on demand. This is the closest study to human use to date.
Not only has this new method shown that rats exhibit a large number of cannabis-related behaviors similar to humans, but more importantly, it has generated more meaningful data from studies on animals. These studies are therefore relevant for the use of cannabis in the human population.
Consumption data has become increasingly important for governments
Strong data on cannabis use has become increasingly important to governments trying to establish reasonable regulations when reforming cannabis laws.
In December, a landmark study published in the Jjournal of the American Medical Association has shown that low doses of CBD did not have a negative impact on driving ability, while THC produces a slight impairment that wears off after about four hours.
Research from the University of Sydney could determine how lawmakers will enforce drinking and driving laws in the years to come.
And further studies on CBD may ultimately lead to the Food and DPlease AAmerican administration to issue rules for ingestible CBD products.
In September, USYD researchers released a paper on how the global cannabidiol craze exceeded its proven efficacy. Due to the lack of clarity in the legal frameworks in nine countries reviewed, many available products did not meet legal requirements and included recommended doses well below the amounts shown to have therapeutic effects in published clinical trials.
The researchers recommended that lawmakers improve guidelines and quality control, while expressing the need for more clinical trials to test the therapeutic benefits of low-dose CBD formulations.
In one of the countries at the forefront of cannabis research, Canada's first pot professor has thoroughly investigated its potential to deal with the opioid epidemic that has been ongoing for more than two years.
And for a healthier society, what about?
In 2020, Dr. Milloy and his research team from BC Center on Substance Use have published several studies on the subject. One, in September, showed how allowing people who inject drugs to have low-barrier access to cannabis could increase their chances of quitting.
Another survey event, linked to the BCCSU in November, showed how the use of cannabis for medical purposes can curb or slow down alcohol consumption, resulting in healthier patients as well as general improvement in health and fitness. public safety.
But not all research on cannabis has explored its potential benefits for a healthier society.
In fact, funds are disproportionately spent on research on vice rather than virtue, as a study published in the journal Science in September showed.
Nonetheless, research shows that cannabis use is risky, especially in certain populations. A study in June showed that pregnant women who consume weed may put their daughters at a higher risk of developing metabolic syndrome later in life, including diabetes, cardiovascular disease and obesity.
While research has reached an all-time high this year, continued reforms are almost certainly going to increase the number of articles on marijuana in 2021.
This month, the US Senate passed a bipartisan bill that is expected to help streamline cannabis research in the country and encourage the FDA to develop drugs derived from cannabis.